Tech Company Financing Transactions
Prolexys Pharmaceuticals Funding Round
Prolexys Pharmaceuticals closed a $20 million Series A funding round on 11/6/2008. Backers included private investors.
Transaction Overview
Company Name
Announced On
11/6/2008
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
2150 West Dauntless Avenue (1000 North)
Salt Lake City, UT 84116
USA
Salt Lake City, UT 84116
USA
Phone
Website
Email Address
Not Recorded
Overview
Prolexys Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering small molecule drugs that act at novel therapeutic targets. The Company's therapeutic focus is on cancer and cardiovascular indications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Sudhir Sahasrabudhe
VP - Operations
Tracy Erkkila
Browse more venture capital transactions:
Prev: 11/6/2008: GetBack Media venture capital transaction
Next: 11/6/2008: Mogreet venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs